Jill Lacy, MD

Professor of Medicine (Medical Oncology)

Clinical Interests

  • Hodgkin Disease
  • Lymphoma
  • Medical Oncology

Patient Care

Accepts new patients? Yes
Patient Type: Adult
Referrals: From patients or physicians

Patient Care Organizations

Cancer Center, Yale: Brain Tumor Center | Gastrointestinal Cancer Program | Sarcoma Oncology Program

Medical Oncology: Subset Medical Oncology Faculty

Yale Medical Group

Board Certifications

  • Internal Medicine AB of Internal Medicine (1982)

Clinical Trials

Conditions Study Title
Liver Phase I/II Study of MEDI4736+Tremelimumab or Monotherapy in Subjects with Hepatocellular Carcinoma
Stomach Study of Pembrolizumab (MK-3475) as First-Line Monotherapy and Combination Therapy for Treatment
Esophagus NCI 9824: Alisertib and Combination Chemotherapy in Treating Patients With Gastrointestinal Tumors
Stomach A Phase I Study of TAS-102 + Irinotecan and Bevacizumab
Bladder, Lung, Other Digestive Organ, Other Urinary, Stomach Ramucirumab + Pembro with Gastric or GEJ Adenocarcinoma, NSCLC or Tcell carcinoma of urothelium
Other Digestive Organ, Pancreas E2211: Phase II study of Temozolomide or Temozolomide + Capecitabine in Patients w Pancreatic Tumors
Pancreas Phase II Gemcitabine & Nab-paclitaxel +/- NPC-1C in metastatic or locally advanced pancreatic cancer
Brain and Nervous System Phase II Rituximab Combined with Temozolomide as Treatment for Patients with Primary CNS Lymphoma
Other Digestive Organ Phase Ib study of DKN-01 plus gemcitabine and cisplatin in pts biliary system or gallbladder cancer
Other Digestive Organ, Stomach Phase 3 study of Ramucirumab in combination with Capecitabine & Cisplatin in pts with stomach cancer
Breast - Female, Breast - Male, Lung, Pancreas Nivolumab in combination with nab-paclitaxel based therapy in Panc, NSCLC, and mBC
Pancreas Olaparib in gBRCA Mutated Pancreatic Cancer pts Not Progressed on 1st Line Platinum-Based Chemo
Esophagus, Other Digestive Organ Phase 1 study of DKN-01 plus Paclitaxel in pts with relapsed or refractory esophageal or GEJ cancer
Colon Pilot Study of Xolair in Reducing Oxaliplatin-induced HSR
Colon, Rectum S1406: Phase II study of irinotecan and cetuximab +/- vemurafenib in BRAF mutant metastatic CRC
Pancreas nab-paclitaxel plus gemcitabine in subjects with locally advanced pancreatic cancer
Pancreas Phase 3 study of adjuvant nab-Paclitaxel + gemcitabine vs. gemcitabine in resected pancreatic cancer
Pancreas S1313: Phase Ib/II Study of mFOLFIRINOX +PEGPH20 vs. mFOLFIRINOX in Met. Pancreatic Adenocarcinoma
Colon S0820: Preventing Adenomas of the Colon with Eflornithine and Sulindac
Colon, Kidney, Lung, Other Digestive Organ, Rectum, Stomach Phase Ib Trial of MPDL3280A with Bev or with Bev + FOLFOX in Patients with Solid Tumors

Edit this profile

Contact Info

Jill Lacy, MD
Patient Care Location
Smilow Cancer Hospital at Yale-New HavenYale-New Haven Hospital
20 York Street, Ste North Pavilion 8

New Haven, CT 06510
View on map...
Mailing Address
PO Box 208028
New Haven, CT 06520-8028